McKesson issues $2B notes to fund acquisition of 70% stake in Community Oncology Revitalization

MCKESSON CORP

Issued $650M 4.650% notes due 2030, $650M 4.950% notes due 2032, $700M 5.250% notes due 2035.
Net proceeds ~$1.99B; combined with cash on hand to fund acquisition of 70% controlling interest in Community Oncology Revitalization Enterprise Ventures (Florida Cancer Specialists).
Interest payable semi-annually on May 30 and Nov 30, starting Nov 30, 2025.
Notes are unsecured, unsubordinated, rank equally with existing unsecured debt; change of control/rating downgrade triggers repurchase offer at 101% plus accrued interest.
Underwriters include Barclays, BofA Securities, Deutsche Bank, J.P. Morgan.

item 2.03item 8.01item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.